Article Details

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic ...

Retrieved on: 2021-01-05 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic .... View article details on hiswai:

Excerpt

“We invested in IconOVir based on the stellar combination of team experience and the company's high throughput synthetic and systems biology ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up